Elevance Health, Inc. (ELV) operating KPIs
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)
Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –
Elevance Health carelonRx Segment — GAAP Operating Gain ($M)
Quarterly figures from Elevance Health's filings and investor materials
Latest, Q3 2026
616
Period ended Sep 30, 2026
Change on a year earlier
+10.8%
556 in Q3 2025
History
22 quarters
Since Q2 2020
Sources
15
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up carelonrx segment — gaap operating gain
Cite this data
StockData. (2026). Elevance Health CarelonRx Segment — GAAP Operating Gain ($M), quarterly Q2 2020–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg_op_gain_carelonrx
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.